Blog
RSS FeedPosted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...
Posted by Michael Wonder on 17 Dec 2019
Lamotrigine NPPA change
17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...
Posted by Michael Wonder on 17 Dec 2019
Spinraza funding application reviewed by the Rare Disorders Subcommittee
17 December 2019 - PHARMAC has published the Rare Disorders Subcommittee meeting records which recommends Spinraza (nusinersen), a medication for ...
Posted by Michael Wonder on 16 Dec 2019
PHARMAC knew of epilepsy deaths for weeks but stayed silent
17 December 2019 - PHARMAC knew for more than two weeks that three deaths had been linked to its epilepsy ...
Posted by Michael Wonder on 16 Dec 2019
Flawed forecasting? Why New Zealand ran out of MMR vaccine
16 December 2019 - PHARMAC's forecast for how many doses of MMR vaccine would be needed for 2019 was around ...
Posted by Michael Wonder on 16 Dec 2019
Proposal to widen funded access to lenalidomide for multiple myeloma
16 December 2019 - PHARMAC is seeking feedback on a proposal to widened funded access to lenalidomide (Revlimid) to include ...
Posted by Michael Wonder on 12 Dec 2019
Decision to award sole supply for fluticasone and fluticasone with salmeterol metered dose inhalers
12 December 2019 - PHARMAC has made a decision to make changes to the funded brands of fluticasone and fluticasone ...
Posted by Michael Wonder on 11 Dec 2019
Decision to award sole supply for apomorphine hydrochloride
11 December 2019 - PHARMAC are pleased to announce changes to the funding of apomorphine hydrochloride, a medicine used to ...
Posted by Michael Wonder on 09 Dec 2019
Proposals for funding in the blood, alimentary and immunosuppressant therapy areas
9 December 2019 - PHARMAC is seeking feedback on proposals to widen funded access to medicines in the blood, alimentary ...
Posted by Michael Wonder on 06 Dec 2019
PHARMAC says it welcomes a joint inquiry into four deaths - which have all been linked to the anti-epileptic drug, Logem
6 December 2019 - Chief Coroner Judge Deborah Marshall made the announcement today. ...
Posted by Michael Wonder on 05 Dec 2019
Epilepsy patients angry at being told symptoms all in their heads
5 December 2019 - PHARMAC funded research into whether people with epilepsy were imagining side effects from a medicine brand change ...
Posted by Michael Wonder on 05 Dec 2019
PHARMAC funded video downplays side effects of drug linked to four unexplained deaths, epilepsy patients say
5 December 2019 - Epilepsy patients are upset about a PHARMAC funded video which they say downplays the side effects of ...
Posted by Michael Wonder on 05 Dec 2019
PHARMAC announces faster assessment of cancer medicines
4 December 2019 - From 1 January 2020, PHARMAC will assess funding applications for new cancer medicines at the same ...
Posted by Michael Wonder on 05 Dec 2019
Decision to widen access to rituximab and award sole supply
5 December 2019 - PHARMAC has made a decision to make changes to the funding of rituximab, including widening access and ...
Posted by Michael Wonder on 05 Dec 2019
Decision to widen access to bortezomib for multiple myeloma and AL amyloidosis
5 December 2019 - PHARMAC is pleased to announce a decision to widen access to bortezomib for patients with multiple ...